All the information you need to install and to download Refinitiv Eikon. Direct link to test if your system can run Refinitiv Eikon.

5 days ago · Eikon emerged publicly in 2021 with a stated goal to apply live-cell super-resolution microscopy to drug discovery.

Eikon Therapeutics filed for an initial public offering. The late-stage clinical biopharmaceutical company didn't disclose in its Friday filing the price or amount of shares it would offer. It ...

3 days ago · Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for more on the upcoming EIKN offering.

Feb 26, 2025 · Eikon was formed around a Nobel Prize-winning technology that helps scientists look at how proteins move inside of cells. The company debuted publicly in 2021 with Roger Perlmutter, …

Jan 9, 2026 · Clinical biopharmaceutical company Eikon Therapeutics on Friday revealed wider nine-month losses in its filing for an initial public offering in the United States.

Jan 9, 2026 · Eikon Therapeutics filed for a Nasdaq IPO after raising $1.1 billion for cancer drugs, led by ex-Amgen and Merck exec Roger Perlmutter.

Eikon Therapeutics is a late-stage clinical biopharmaceutical firm developing innovative medicines for serious unmet medical needs, with an initial focus on oncology.

4 days ago · Eikon Therapeutics Planning IPO HAYWARD, Calif., Jan. 13, 2026 — Biotechnology company Eikon Therapeutics is planning to go public through an initial public offering, according to a …

Feb 26, 2025 · Since its founding in 2019, Eikon Therapeutics has privately raised in excess of $1.1 billion to support its mission of developing new medicines to address grievous illnesses.